LARUPARETIGENE ZOVAPARVOVEC
UNII 8OPK0FI6EM

Substance Identification & Data

This profile provides standardized clinical and technical data for Laruparetigene Zovaparvovec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8OPK0FI6EM.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2425817-08-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
8OPK0FI6EM
CAS Registry Number
2425817-08-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LARUPARETIGENE ZOVAPARVOVEC
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12108
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
JK-72
Identifier assigned by the United States Adopted Names Council.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Laruparetigene Zovaparvovec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LARUPARETIGENE ZOVAPARVOVEC

Common Names & Synonyms

AGTC-501
DNA (RECOMBINANT ADENO-ASSOCIATED VIRUS SEROTYPE AAV2TYF VECTOR RAAV2TYF-GRK1-RPGRCO HUMAN RETINITIS PIGMENTOSA GTPASE REGULATOR ORF15 CODON-OPTIMIZED CDNA PLUS 5'-HUMAN G PROTEIN-COUPLED RECEPTOR KINASE 1 PROMOTER AND SPLICE DONOR/SPLICE ACCEPTOR AND 3'-SV40 POLYADENYLATION SIGNAL PLUS ADENO-ASSOCIATED VIRUS 2 INVERTED TERMINAL REPEAT FLANKS)
LARUPARETIGENE ZOVAPARVOVEC [INN]
LARUPARETIGENE ZOVAPARVOVEC [USAN]